BioPharma Dive November 22, 2024
Jonathan Gardner and Ned Pagliarulo

A prolific medical research and author, Marty Makary criticized the FDA and CDC for their decision-making during the pandemic, although he describes himself as pro-vaccine.

President-elect Donald Trump on Friday named Johns Hopkins University surgeon Marty Makary to lead the Food and Drug Administration, choosing a prolific medical researcher who bucked consensus on the necessity of frequent vaccination during the COVID-19 pandemic.

As FDA commissioner, Makary would oversee an agency of some 18,000 employees who assess new drugs and devices, review the performance of approved medicines and monitor food quality and safety. The agency typically evaluates and makes decisions on more than 50 new drug and biological products each year.

Makary, whose specialty is pancreatic surgery, is something of a...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Congress / White House, FDA, Govt Agencies
Trump names nominees to lead CDC, FDA, and his pick for surgeon general
Patient Dies in Gene Therapy Trial, But FDA Permits Neurogene to Proceed With Low Dose
New FDA Panel Weighs In on Regulating Generative AI in Healthcare
Trump's FDA Pick Is MedPage Today's Former Top Editor
1st gene therapy delivered directly into brain approved

Share This Article